Dear Health Care Professional Letter Refludan 2012 final

First Page		Document Content
Date: 2012-10-04 17:58:42 Direct thrombin inhibitors Medical emergencies Lepirudin Thrombocytopenia Heparin Thrombolytic drug Thrombolysis Bleeding Coagulation Medicine Hematology Health		Dear Health Care Professional Letter Refludan 2012 final Add to Reading List Source URL: www.hrsa.gov Download Document from Source Website File Size: 115,50 KB Share Document on Facebook

	Markedly Reduced Apparent Blood Volume on Bolus Contrast Magnetic Resonance Imaging as a Predictor of Hemorrhage After Thrombolytic Therapy for Acute Ischemic Stroke David C. Alsop, PhD; Elena Makovetskaya, BS; Sandeep K DocID: 1gj3y - View Document
	Version 8.0. To be used for all acute stroke registrations from 1 January 2007 onwards RIKS-STROKE - ACUTE PHASE Personal ID number I___I___I___I___I___I___II___I___I___I___I Gender DocID: 1fGnj - View Document
	Version 14.a To be used for all acute stroke registrations from 1 January 2014 onwards. To register a TIA diagnosis without thrombolytic therapy please use separate TIA form. DocID: 1fsHj - View Document
	Review Streamlining of prehospital stroke management: the golden hour Klaus Fassbender, Clotilde Balucani, Silke Walter, Steven R Levine, Anton Haass, James Grotta DocID: 1aPb6 - View Document
	International Journal of Technology Assessment in Health Care, 20:), 537–544. c 2004 Cambridge University Press. Printed in the U.S.A. Copyright Influences upon the diffusion of thrombolysis for acute myocardi DocID: 1aKi1 - View Document